JPH08511550A - N‐アセチルノイラミン酸誘導体の製造法 - Google Patents
N‐アセチルノイラミン酸誘導体の製造法Info
- Publication number
- JPH08511550A JPH08511550A JP7502407A JP50240795A JPH08511550A JP H08511550 A JPH08511550 A JP H08511550A JP 7502407 A JP7502407 A JP 7502407A JP 50240795 A JP50240795 A JP 50240795A JP H08511550 A JPH08511550 A JP H08511550A
- Authority
- JP
- Japan
- Prior art keywords
- catalyst
- formula
- compound
- formic acid
- carried out
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims description 24
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical class CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 title description 2
- 238000004519 manufacturing process Methods 0.000 claims abstract description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 34
- 239000003054 catalyst Substances 0.000 claims description 27
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical group [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 18
- 150000001875 compounds Chemical class 0.000 claims description 18
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 17
- 235000019253 formic acid Nutrition 0.000 claims description 17
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 9
- 229910052763 palladium Inorganic materials 0.000 claims description 8
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical group [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 230000007062 hydrolysis Effects 0.000 claims description 4
- 238000006460 hydrolysis reaction Methods 0.000 claims description 4
- 238000002955 isolation Methods 0.000 claims description 4
- 239000011541 reaction mixture Substances 0.000 claims description 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 125000002252 acyl group Chemical group 0.000 claims description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 2
- 239000011981 lindlar catalyst Substances 0.000 claims description 2
- 239000012736 aqueous medium Substances 0.000 claims 1
- 239000007795 chemical reaction product Substances 0.000 claims 1
- 238000006722 reduction reaction Methods 0.000 claims 1
- JABYJIQOLGWMQW-UHFFFAOYSA-N undec-4-ene Chemical compound CCCCCCC=CCCC JABYJIQOLGWMQW-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 abstract description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 14
- 239000000243 solution Substances 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- -1 peracetyl NANA methyl ester Chemical class 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 150000004702 methyl esters Chemical class 0.000 description 3
- 150000007530 organic bases Chemical class 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000012296 anti-solvent Substances 0.000 description 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 230000000850 deacetylating effect Effects 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000002940 palladium Chemical class 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 150000004684 trihydrates Chemical class 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
- Pyrane Compounds (AREA)
- Glass Compositions (AREA)
- Iron Core Of Rotating Electric Machines (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 下記の式(I)の化合物の製造法であって、 式(II)の化合物をギ酸中で接触水素添加する工程を含んでなる、方法。 (ここで、RはHまたはC1-4アルキル基を表し、R1はHまたは水酸基の保護基 、例えばアセチルのようなアシル基を表す) 2. 触媒がパラジウム触媒である、請求項1記載の方法。 3. 触媒がわずかに不活性化された触媒である、請求項2記載の方法。 4. 触媒が鉛でわずかに不活性化された触媒である、請求項1〜3のいずれ か一項に記載の方法。 5. 触媒がリンドラー触媒である、請求項1〜4のいずれか一項に記載の方 法。 6. 触媒が担体上の5%パラジウムおよび3〜7%の鉛を含んでなるもので ある、請求項1〜5のいずれか一項に記載の方法。 7. 担体が炭酸カルシウムである、請求項6記載の方法。 8. 鉛含有率が5%である、請求項6または7記載の方法。 9. ギ酸を式(II)の化合物に対して1〜4モル当量存在させる、請求項1 〜8のいずれか一項に記載の方法。 10. ギ酸を式(II)の化合物に対して2モル当量存在させる、請求項9記 載の方法。 11. 反応を0〜50℃の温度で実施する、請求項1〜10のいずれか一項 に記載の方法。 12. 式(II)の化合物がRまたはR1の少なくとも一方が水素原子である ものであり、還元反応生成物を続いて加水分解する、請求項1〜10のいずれか 一項に記載の方法。 13. 加水分解が水性媒体中で実施される、請求項12記載の方法。 14. 加水分解がトリエチルアミンおよび1,8−ジアザビシクロ[5.4 .0]ウンデカ−7−エンから選択される塩基を用いて実施される、請求項12 または13記載の方法。 15. 式(I)の化合物の単離に先立ち、反応混合物のpHが3〜9の範囲 に調整される、請求項1〜14のいずれか一項に記載の方法。 16. pHを約6.5に調整する、請求項15記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939312531A GB9312531D0 (en) | 1993-06-17 | 1993-06-17 | Process |
GB9312531.8 | 1993-06-17 | ||
PCT/EP1994/001940 WO1995000503A1 (en) | 1993-06-17 | 1994-06-15 | Process for the preparation of n-acetyl neuraminic acid derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH08511550A true JPH08511550A (ja) | 1996-12-03 |
JP3298644B2 JP3298644B2 (ja) | 2002-07-02 |
Family
ID=10737336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50240795A Expired - Lifetime JP3298644B2 (ja) | 1993-06-17 | 1994-06-15 | N‐アセチルノイラミン酸誘導体の製造法 |
Country Status (18)
Country | Link |
---|---|
US (1) | US5597933A (ja) |
EP (1) | EP0705256B1 (ja) |
JP (1) | JP3298644B2 (ja) |
CN (1) | CN1061343C (ja) |
AT (1) | ATE172198T1 (ja) |
AU (1) | AU687825B2 (ja) |
CA (1) | CA2165329C (ja) |
CY (1) | CY2184B1 (ja) |
DE (1) | DE69413974T2 (ja) |
DK (1) | DK0705256T3 (ja) |
ES (1) | ES2125463T3 (ja) |
FI (1) | FI111941B (ja) |
GB (1) | GB9312531D0 (ja) |
HK (1) | HK1011995A1 (ja) |
HU (1) | HU213451B (ja) |
NO (1) | NO312675B1 (ja) |
SG (1) | SG48162A1 (ja) |
WO (1) | WO1995000503A1 (ja) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9607098B8 (pt) * | 1995-02-27 | 2014-11-18 | Gilead Sciences Inc | Composto e composição farmacêutica. |
US5866601A (en) * | 1995-02-27 | 1999-02-02 | Gilead Sciences, Inc. | Carbocyclic compounds |
US5763483A (en) * | 1995-12-29 | 1998-06-09 | Gilead Sciences, Inc. | Carbocyclic compounds |
US6518438B2 (en) | 1996-08-23 | 2003-02-11 | Gilead Sciences, Inc. | Preparation of cyclohexene carboxylate derivatives |
US5859284A (en) | 1996-08-23 | 1999-01-12 | Gilead Sciences, Inc. | Preparation of carbocyclic compounds |
US5994377A (en) | 1996-10-21 | 1999-11-30 | Gilead Sciences, Inc. | Piperidine compounds |
US5886213A (en) * | 1997-08-22 | 1999-03-23 | Gilead Sciences, Inc. | Preparation of carbocyclic compounds |
US20040053999A1 (en) * | 1997-09-17 | 2004-03-18 | Bischofberger Norbert W. | Novel compounds and methods for synthesis and therapy |
TW477783B (en) * | 1997-12-12 | 2002-03-01 | Gilead Sciences Inc | Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same |
US7636596B2 (en) * | 2002-12-20 | 2009-12-22 | Medtronic, Inc. | Organ access device and method |
KR101142052B1 (ko) | 2010-02-18 | 2012-07-19 | 한미약품 주식회사 | 자나미비어의 제조방법 |
CN101962375B (zh) * | 2010-09-21 | 2012-05-23 | 仙居县圃瑞药业有限公司 | 扎那米韦中间体叠氮还原工艺方法 |
EA201692111A1 (ru) | 2014-05-12 | 2017-08-31 | Глаксосмитклайн Интеллекчуал Проперти (№ 2) Лимитед | Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK282950B6 (sk) * | 1990-04-24 | 2003-01-09 | Biota Scientific Management Pty Ltd | Deriváty alfa-D-neuramínovej kyseliny, spôsob ich prípravy, ich použitie a farmaceutické prípravky na ich báze |
GB9126725D0 (en) * | 1991-12-17 | 1992-02-12 | Glaxo Group Ltd | Process |
-
1993
- 1993-06-17 GB GB939312531A patent/GB9312531D0/en active Pending
-
1994
- 1994-06-15 ES ES94918871T patent/ES2125463T3/es not_active Expired - Lifetime
- 1994-06-15 WO PCT/EP1994/001940 patent/WO1995000503A1/en active IP Right Grant
- 1994-06-15 AT AT94918871T patent/ATE172198T1/de active
- 1994-06-15 SG SG1996007494A patent/SG48162A1/en unknown
- 1994-06-15 EP EP94918871A patent/EP0705256B1/en not_active Expired - Lifetime
- 1994-06-15 AU AU70006/94A patent/AU687825B2/en not_active Expired
- 1994-06-15 HU HU9503599A patent/HU213451B/hu unknown
- 1994-06-15 CA CA002165329A patent/CA2165329C/en not_active Expired - Lifetime
- 1994-06-15 CN CN94192472A patent/CN1061343C/zh not_active Expired - Lifetime
- 1994-06-15 JP JP50240795A patent/JP3298644B2/ja not_active Expired - Lifetime
- 1994-06-15 DK DK94918871T patent/DK0705256T3/da active
- 1994-06-15 US US08/549,820 patent/US5597933A/en not_active Expired - Lifetime
- 1994-06-15 DE DE69413974T patent/DE69413974T2/de not_active Expired - Lifetime
-
1995
- 1995-12-14 FI FI955993A patent/FI111941B/fi not_active IP Right Cessation
- 1995-12-15 NO NO19955124A patent/NO312675B1/no not_active IP Right Cessation
-
1998
- 1998-12-14 HK HK98113326A patent/HK1011995A1/xx not_active IP Right Cessation
-
1999
- 1999-01-14 CY CY9900002A patent/CY2184B1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP0705256A1 (en) | 1996-04-10 |
FI111941B (fi) | 2003-10-15 |
CA2165329A1 (en) | 1995-01-05 |
CN1125441A (zh) | 1996-06-26 |
CN1061343C (zh) | 2001-01-31 |
ES2125463T3 (es) | 1999-03-01 |
DE69413974D1 (de) | 1998-11-19 |
AU7000694A (en) | 1995-01-17 |
HU213451B (en) | 1997-06-30 |
EP0705256B1 (en) | 1998-10-14 |
NO312675B1 (no) | 2002-06-17 |
CY2184B1 (en) | 2002-11-08 |
ATE172198T1 (de) | 1998-10-15 |
JP3298644B2 (ja) | 2002-07-02 |
DE69413974T2 (de) | 1999-03-11 |
NO955124D0 (no) | 1995-12-15 |
HU9503599D0 (en) | 1996-02-28 |
SG48162A1 (en) | 1998-04-17 |
WO1995000503A1 (en) | 1995-01-05 |
FI955993A0 (fi) | 1995-12-14 |
CA2165329C (en) | 2002-08-20 |
US5597933A (en) | 1997-01-28 |
HUT73561A (en) | 1996-08-28 |
GB9312531D0 (en) | 1993-08-04 |
FI955993A (fi) | 1995-12-14 |
HK1011995A1 (en) | 1999-07-23 |
AU687825B2 (en) | 1998-03-05 |
DK0705256T3 (da) | 1999-06-23 |
NO955124L (no) | 1995-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3834203B2 (ja) | 新規のHMG−CoAレダクターゼインヒビターの塩 | |
JPH08511550A (ja) | N‐アセチルノイラミン酸誘導体の製造法 | |
JPH09202796A (ja) | 新規なパクリタキセルプロドラッグ、製造方法およびその選択的化学療法における使用 | |
JP3295082B2 (ja) | N−アセチルノイラミン酸誘導体の製造法 | |
CA1100487A (en) | Process for the preparation of alpha-l-aspartyl-l- phenylalanine methyl ester | |
EP0662967B1 (en) | Synthesis of n-acetyl neuraminic acid derivatives | |
JP3166125B2 (ja) | インドール誘導体の製法 | |
EP1265884A1 (en) | A process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities | |
US4061676A (en) | Recovery of doxycycline and products thereof | |
CA2780183C (en) | A method for preparing a statin compound by lactonization | |
JP4870320B2 (ja) | ヒドロキシカルボン酸の結晶化法 | |
JP2711828B2 (ja) | (6r)−テトラヒドローl−バイオプテリン塩酸塩の製造法 | |
WO2004026860A1 (ja) | 結晶析出方法 | |
GB1589954A (en) | Everninomicin derivatives and their preparation | |
BG107477A (bg) | Лактонизационен метод за получаване на симвастатин с висока чистота | |
JPH09505999A (ja) | 酵素によるモルフィン−6−グルクロニドまたは置換モルフィン−6−グルクロニドの製造方法 | |
JP2001055397A (ja) | 2’−デオキシウリジンの製造法 | |
JPH0139412B2 (ja) | ||
JP2723591B2 (ja) | 7―/D(―)アルフア―アミノ―アルフア―(p―ヒドロキシフエニル)アセトアミド/―3―メチル―3―セフエム―4―カルボン酸―水化物の製造方法 | |
JP2886576B2 (ja) | シクロヘキサンカルボン酸誘導体の製法 | |
JPH10114740A (ja) | 高品質カプトプリルの簡便な製造方法 | |
JPH09221495A (ja) | エトポシドの異性体の生成を抑える方法 | |
JPH03141253A (ja) | モノバクテーム及びそれらの中間体生成物の調製方法 | |
JP2000178294A (ja) | ペンタアセチル―β―D―グルコ―スの製造方法 | |
JPH05331106A (ja) | フェニル酢酸誘導体の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080419 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090419 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100419 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110419 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120419 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120419 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130419 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130419 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140419 Year of fee payment: 12 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |